Shattuck Labs, Inc. Capital Expenditures
Shattuck Labs, Inc. (STTK) reported Capital Expenditures of $141.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-11
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $71.00K, a 69.05% increase year-over-year.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $42.00K, a 121.05% increase year-over-year.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $71.00K, a 20.34% increase from fiscal 2024.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $59.00K, a 85.50% decline from fiscal 2023.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $407.00K, a 96.50% decline from fiscal 2022.
- Shattuck Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $11.61M, a 46.53% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $141.00K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $71.00K derived: sum of 2 quarters · filed 2026-03-05 | $71.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $71.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $42.00K derived: sum of 2 quarters · filed 2026-03-05 | $59.00K derived: sum of 3 quarters · filed 2026-03-05 | $59.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $59.00K derived: sum of 2 quarters · filed 2025-11-06 | $59.00K 10-Q · filed 2025-11-06 | $76.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $17.00K 10-Q · filed 2025-08-14 | $34.00K derived: sum of 3 quarters · filed 2025-08-14 | $53.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $17.00K derived: sum of 2 quarters · filed 2025-03-27 | $36.00K derived: sum of 3 quarters · filed 2025-03-27 | $332.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $36.00K derived: sum of 2 quarters · filed 2025-03-27 | $332.00K derived: sum of 3 quarters · filed 2025-03-27 | $407.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $315.00K derived: sum of 2 quarters · filed 2024-11-14 | $390.00K 10-Q · filed 2024-11-14 | $1.08M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $296.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $371.00K 10-Q · filed 2024-08-01 | $1.06M derived: sum of 3 quarters · filed 2024-08-01 | $1.81M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $75.00K 10-Q · filed 2024-05-02 | $768.00K derived: sum of 2 quarters · filed 2024-05-02 | $1.52M derived: sum of 3 quarters · filed 2024-05-02 | $9.20M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.44M derived: sum of 2 quarters · filed 2024-02-29 | $9.13M derived: sum of 3 quarters · filed 2024-02-29 | $11.61M 10-K · filed 2024-02-29 |
| 2022-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $8.43M derived: sum of 2 quarters · filed 2023-11-09 | $10.92M 10-Q · filed 2023-11-09 | $12.91M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $7.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $10.17M 10-Q · filed 2023-08-10 | $12.16M derived: sum of 3 quarters · filed 2023-08-10 | $13.13M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.49M 10-Q · filed 2023-05-09 | $4.48M derived: sum of 2 quarters · filed 2023-05-09 | $5.44M derived: sum of 3 quarters · filed 2023-05-09 | $7.78M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.95M derived: sum of 2 quarters · filed 2023-02-23 | $5.29M derived: sum of 3 quarters · filed 2023-02-23 | $7.93M 10-K · filed 2023-02-23 |
| 2021-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.30M derived: sum of 2 quarters · filed 2022-11-09 | $5.94M 10-Q · filed 2022-11-09 | $6.14M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $4.97M 10-Q · filed 2022-08-11 | $5.17M derived: sum of 3 quarters · filed 2022-08-11 | $5.27M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.64M 10-Q · filed 2022-05-12 | $2.84M derived: sum of 2 quarters · filed 2022-05-12 | $2.94M derived: sum of 3 quarters · filed 2022-05-12 | $3.26M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $300.00K derived: sum of 2 quarters · filed 2022-03-15 | $619.00K derived: sum of 3 quarters · filed 2022-03-15 | $727.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $418.00K derived: sum of 2 quarters · filed 2021-11-09 | $526.00K 10-Q · filed 2021-11-09 | $551.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $319.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $427.00K 10-Q · filed 2021-08-12 | $452.00K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $108.00K 10-Q · filed 2021-05-10 | $133.00K derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $470.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $445.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |